(2S)-N-[(2S,4R,5S)-5-[[2-(2,6-dimethylphenoxy)acetyl]amino]-4-hydroxy-1,6-diphenylhexan-2-yl]-3-methyl-2-(2-oxo-1,3-diazinan-1-yl)butanamide

1798014-18-2

CAS-Nr.: 1798014-18-2

Englisch Name:: (2S)-N-[(2S,4R,5S)-5-[[2-(2,6-dimethylphenoxy)acetyl]amino]-4-hydroxy-1,6-diphenylhexan-2-yl]-3-methyl-2-(2-oxo-1,3-diazinan-1-yl)butanamide

Synonyma:: (rel)-Lopinavir;Lopinavir EP Imp N;Lopinavir EP impurity N;Lopinavir Impurity 14（Lopinavir EP Impurity N）;(2S)-N-[(2S,4R,5S)-5-[[2-(2,6-dimethylphenoxy)acetyl]amino]-4-hydroxy-1,6-diphenylhexan-2-yl]-3-methyl-2-(2-oxo-1,3-diazinan-1-yl)butanamide;(2S)-N-[(1S,3R,4S)-1-benzyl-4-[[2-(2,6-dimethylphenoxy)acetyl]amino]-3-hydroxy-5-phenylpentyl]-3-methyl-2-[2-oxotetrahydropyrimidin-1(2H)-yl]butanamide,;1(2H)-Pyrimidineacetamide, N-[(1R,3S,4R)-4-[[2-(2,6-dimethylphenoxy)acetyl]amino]-3-hydroxy-5-phenyl-1-(phenylmethyl)pentyl]tetrahydro-α-(1-methylethyl)-2-oxo-, (αR)-rel-

CBNumber:: CB93939773

Summenformel:: C37H48N4O5

Molgewicht:: 628.8

MOL-Datei:: 1798014-18-2.mol

Request For Quotation

Eigenschaften Sicherheit Verwendungswort Produktionsfirma 17

(2S)-N-[(2S,4R,5S)-5-[[2-(2,6-dimethylphenoxy)acetyl]amino]-4-hydroxy-1,6-diphenylhexan-2-yl]-3-methyl-2-(2-oxo-1,3-diazinan-1-yl)butanamide Eigenschaften

Siedepunkt:: 924.1±65.0 °C(Predicted)

Dichte: 1.163±0.06 g/cm3(Predicted)

pka: 13.89±0.46(Predicted)

Sicherheit

(2S)-N-[(2S,4R,5S)-5-[[2-(2,6-dimethylphenoxy)acetyl]amino]-4-hydroxy-1,6-diphenylhexan-2-yl]-3-methyl-2-(2-oxo-1,3-diazinan-1-yl)butanamide Chemische Eigenschaften,Einsatz,Produktion Methoden

Verwenden

(2S,4R,5S)-Lopinavir (Lopinavir EP Impurity N) is a diastereomer of Lopinavir (L469480); a selective HIV protease inhibitor and antiviral. It is a COVID19-related research product.

(2S)-N-[(2S,4R,5S)-5-[[2-(2,6-dimethylphenoxy)acetyl]amino]-4-hydroxy-1,6-diphenylhexan-2-yl]-3-methyl-2-(2-oxo-1,3-diazinan-1-yl)butanamide Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

(2S)-N-[(2S,4R,5S)-5-[[2-(2,6-dimethylphenoxy)acetyl]amino]-4-hydroxy-1,6-diphenylhexan-2-yl]-3-methyl-2-(2-oxo-1,3-diazinan-1-yl)butanamide Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global( 17)Lieferanten

Firmenname	Telefon	E-Mail	Land	Produktkatalog	Edge Rate
Standardpharm Co. Ltd.	86-714-3992388	overseasales1@yongstandards.com	United States	14332	58
CR Corporation Limited	+8613062833949	fred.wen@crcorporation.cn	China	8647	58
Guangzhou PI PI Biotech Inc	020-81716320 +86-13602409664	Sales@pipitech.com	China	3633	55
BOC Sciences	1-631-485-4226; 16314854226	info@bocsci.com	United States	14055	65
BOC Sciences	16314854226	info@bocsci.com	United States	9923	65
Hubei Yangxin Medical Technology Co., Ltd.	15374522761	3003392093@qq.com	China	8378	55
Shanghai CR Corporation Limited	021-80270511; 4006653949	fred.wen@crcorporation.cn	China	10044	58
Jinan blalong chemical co. LTD	2710913286@.com	1513643261@qq.com	China	14246	58
Cato Research Chemicals Inc.	020-81215950 4000-868-328	customer@uwalab.com	United States	10404	58
Meng Cheng Technology (Shanghai) Co., LTD	400-820-6829	sales@mitachieve.com	China	8860	58

Lopinavir EP Imp N
Lopinavir Impurity 14（Lopinavir EP Impurity N）
(2S)-N-[(2S,4R,5S)-5-[[2-(2,6-dimethylphenoxy)acetyl]amino]-4-hydroxy-1,6-diphenylhexan-2-yl]-3-methyl-2-(2-oxo-1,3-diazinan-1-yl)butanamide
Lopinavir EP impurity N
1(2H)-Pyrimidineacetamide, N-[(1R,3S,4R)-4-[[2-(2,6-dimethylphenoxy)acetyl]amino]-3-hydroxy-5-phenyl-1-(phenylmethyl)pentyl]tetrahydro-α-(1-methylethyl)-2-oxo-, (αR)-rel-
(2S)-N-[(1S,3R,4S)-1-benzyl-4-[[2-(2,6-dimethylphenoxy)acetyl]amino]-3-hydroxy-5-phenylpentyl]-3-methyl-2-[2-oxotetrahydropyrimidin-1(2H)-yl]butanamide,
(rel)-Lopinavir
1798014-18-2